We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




GE Healthcare Completes Acquisition of VersaMed

By HospiMedica staff writers
Posted on 07 Apr 2008
General Electric Healthcare (GE Healthcare) has announced that it has completed the acquisition of VersaMed (Pearl River, NY, USA), a provider of portable critical care ventilators for respiratory care. More...
Financial terms were not disclosed.

The acquisition expands GE Healthcare's capabilities in respiratory care management, offering healthcare professionals a wide choice of VersaMed's high performance, portable intensive care unit (ICU)-grade ventilators. VersaMed's flagship product, the iVent201 ventilator, is designed to be compact and portable, making it suitable for use in hospitals for acute and sub-acute care, in emergency transport, and in the home. The iVent201 has been cleared by the U.S. Food and Drug Administration (FDA) for use in hospitals, home, patient transport, emergency, and alternate-site care venues, and has already been selected by a number of governmental and healthcare organizations as a key part of their pandemic and other emergency preparedness plans.

"VersaMed has a strong track record of customer-focused innovation and a product portfolio that is highly complementary to our existing suite of products for respiratory care,” said Omar Ishrak, President and CEO of GE Healthcare's clinical systems business unit. "We believe that combining the expertise and knowledge of the two businesses will create significant added value for our customers, bringing new technologies to healthcare professionals worldwide. Respiratory care is a key area of growth for GE Healthcare and expanding our skill base and product offering in this area supports our vision of helping our customers meet a wide range of needs, wherever the care setting.”

"The VersaMed team is delighted to be joining GE Healthcare,” said Jerry Korten, CEO of VersaMed. "The combination of VersaMed with GE Healthcare's resources and global reach will allow us to accelerate our development programs and bring our innovative products to a much wider customer base.”

The clinical systems business of GE Healthcare, a unit of General Electric Company (Fairfiled, CT, USA), is a world-class provider of advanced technologies for acute respiratory care. The strategic fit between the two businesses is designed to offer substantial customer benefits through complementary product and service offerings.


Related Links:
General Electric Healthcare
VersaMed

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.